Q3 Pharma TV Advertising Rundown
Download iSpot’s Q3 pharmaceutical TV ad report today to dive into more on brand and creative performance from last quarter, along with more insights on emerging advertisers, top networks and programs.
During new-airing programming, pharmaceutical est. national TV ad spend and TV ad impressions have decreased over the course of 2022 – but are running closely to figures from 2021. In Q3, RINVOQ was the most-seen brand across its various use cases, though it’s far from the only prevalent brand as focus shifts to cable news and the coming election cycle.
Download iSpot’s Q3 pharmaceutical TV ad report today to dive into more on brand and creative performance from last quarter, along with more insights on emerging advertisers, top networks and programs.
Key takeaways from Q3 2022:
- SKYRIZI, RINVOQ and DUPIXENT claimed the top spots among the most-seen pharma brands.
- Fox News, MSNBC and CNN all grew pharmaceutical share of TV ad impressions YoY as well in the lead-up to the 2022 midterm election.
- RINVOQ landed two of the most likeable spot.